Title : Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial.

Pub. Date : 2017

PMID : 28464042






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Patients in each of the two study groups were randomized to receive 90 mg qd of the cyclooxygenase-2 inhibitor etoricoxib for six months, two weeks or to a control arm, respectively. Etoricoxib prostaglandin-endoperoxide synthase 2 Homo sapiens